The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


AstraZeneca elects to return AZD9412 drug rights to Synairgen.....           FDA grants Pfizer?s Lorlatinib breakthrough designation for NSCLC.....           Takeda, Harrington to advance development of rare disease therapeutics.....           Cost cuts and castoffs help AstraZeneca power past Q1 earnings forecast.....           Novartis to pay $50M, lose some drug coverage in Korean bribery probe.....           U.S. biopharma's tax rates? 35% high, 19% low, and all looking for a break.....           Resurgent Humira sales make up for hep C decline, powering AbbVie to Q1 beat.....           Thought Opdivo was down and out? Think again, Bristol-Myers says with first-quarter beats.....           As Supreme Court steps into tangled biosimilars law, IP experts weigh in.....           With FDA nod, BioMarin prices orphan drug Brineura at $702,000, but plans hefty discounts.....           Gates Foundation leads $45.5m round for biotechnology firm Arsanis.....           Teva launches generic Vytorin tablets in US.....           Shire wins EC conditional approval for Natpar to treat hypoparathyroidism.....           Novartis, Pfizer and Amgen top pharma's lobby spending in eventful Q1.....           Neurocrine goes high?$60K-plus high?with price for new movement drug Ingrezza.....           J&J, Bayer face first jury trial over blockbuster Xarelto's bleeding risks.....           AAN rundown: Dueling MS data from Roche, Sanofi and Biogen, plus up-and-coming candidates.....           Teva says it's eyeing a debt-cutting sale of its cancer meds.....           Glaxo's new chief stands by three-unit structure, foreshadows cultural changes amid 'quiet' Q1 results.....           Regeneron CEO, CSO rack up smaller 2016 pay packages as options values sink.....           Amgen, Sandoz take closely watched biosimilars arguments to Supreme Court.....           EC approves AstraZeneca?s Tagrisso to treat mutation-positive NSCLC.....           Clinical trial technology firm Science 37 raises $29m funding.....           uniQure?s gene therapy for severe hemophilia B gets PRIME designation in Europe.....           Akebia expands anemia drug collaboration with Otsuka.....           J&J, Novartis, Takeda eye for-sale stake in Brazilian drugmaker Hypermarcas.....           Pfizer's Zavicefta matches standard-of-care in treating hospital-acquired pneumonia in phase 3 study.....           U.S. Army can't add a pricing safeguard to Sanofi's Zika vaccine license, official says.....           Fresenius pulls off sterile injectables double whammy, snags Akorn as well as Merck KGaA's biosimilars business.....           Longtime Teva CFO Desheh could be next out the struggling drugmaker's door.....           What if EpiPen price hikes were designed to crush rivals? Sanofi suit claims that, and much more.....           Biogen CEO eyes value-based payer deals to boost pressured MS franchise.....           Novartis laggards Entresto, Alcon step up to help keep Q1 sales in line.....           Fresenius Kabi agrees to acquire Akorn for $4.3bn.....           EMA's CHMP recommends approval for Kevzara for rheumatoid arthritis.....           Lilly's cancer med abemaciclib hits survival mark, but can it stand up to Ibrance and Kisqali?.....           Biogen looks to M&A to overcome competition to its MS franchise.....           Samsung biosim nod sets J&J's Remicade up for tough fight with Merck and Pfizer.....           Brace yourself, pharma: Your beloved tax inversions could make a comeback.....           Biogen's Spinraza scores later-onset SMA data for stepped-up push with payers.....           FDA rejects Vernalis? NDA for cough cold treatment.....           Biosimilars to rituximab, etanercept recommended for approval in Europe.....           NGM Bio?s NGM282 succeeds in nonalcoholic steatohepatitis phase 2 trial.....           Lack of demand forces uniQure to withdraw Glybera gene therapy in Europe.....           Empathy matters: Klick Labs device simulates Parkinson's tremors, directly.....           Can art imitate migraine? Allergan campaign asks sufferers to visualize symptoms.....           FiercePharmaAsia?China pharma market prospect, Hanmi?s negligence, Celgene?s Asia-Pacific collaboration.....           Valeant's $3,500 sticker on Siliq could trigger a pricing war with Lilly, Novartis.....           GSK told to pay $3M for Chicago attorney's suicide while on generic Paxil.....           Regeneron's Eylea success makes it 'uniquely exposed' to Medicare payment shift.....           Sawai to buy Upsher-Smith?s generic pharmaceuticals business for $1.05bn.....           Immune Pharmaceuticals licenses cancer treatment's Latin America rights to Pint.....           H3 Biomedicine, Foundation Medicine extend precision oncology collaboration.....           AbbVie's pan-genotypic HCV regimen achieves 99% cure rate in phase 3 study.....           Big Pharma faces $26.5B in losses this year as next big patent cliff looms, analyst says.....           Amgen, already on PCSK9 offense, slaps Sanofi, Regeneron with Dupixent patent suit.....           Pfizer subpoenaed to testify in DOJ's antitrust probe of saline shortages.....           With its launch fizzling out, UniQure gives up on $1M+ gene therapy Glybera.....           Tesaro undercuts PARP rivals with $118K price tag on Zejula?or did it?.....           Pressuring GSK's Advair, Teva launches both AirDuo RespiClick and authorized generic.....           Relypsa?s Veltassa shows consistent efficacy in phase 4 trial to treat hyperkalemia.....           Alpine Immune Sciences to merge with Nivalis Therapeutics.....           Ultragenyx's hypophosphatemia drug succeeds in phase 3 study.....           Novartis signs collaboration deal with Parvus for diabetes nanomedicine.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
PharmSci 2017 - first announcement

Tuesday 5 - Thursday 7 September 2017 at De Havilland Campus, University of Hertfordshire, Hatfield

The theme of the conference in 2017 is:
'Pharmaceutical Science without Borders'

The APS is pleased to announce Professor Abdul Basit as this year's Conference Science Chair.

Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.

"I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is "Pharmaceutical Science without Borders". Pharmaceutical science transcends a multitude of borders - it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event."

You can become part of this conference now.

Reserve the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.

Please also regularly check the PharmSci website for updates.
 

PharmSci 2016 Conference - Chair's review

The Chair of the Academy of Phamaceutical Sciences, Dr Linda Hakes, gives a brief review of the 7th APS International PharmSci Conference, held in Glasgow on 5-7 September 2016.

"2016 has come to an end and although I admit that I am probably biased, I think it was a fantastic three days. The venue, the Technology and Innovation Centre at Strathclyde University, was well equipped to handle the conference and the facilities are modern and efficient.

All of the conference sessions (as far as I could tell) were well attended and the plenary lectures were all excellent, covering topics ranging across the spectrum of pharmaceutical sciences, embracing chemistry, pharmacology, medical devices, formulation, pharmacokinetics and spectroscopy.

A highlight of the social side was the Civic Reception in the City Chambers, a magnificent building on George Square, where we were warmly welcomed by the Bailey Steward on behalf of the Lord Provost of Glasgow.

 

 

 

 

 

As always the Black Tie Dinner was a great success and we were pleased to have Prof. Sandy Florence as guest speaker. Again, the venue was truly impressive – the Barony Hall.

 

 

 

 


To sum up, I believe we enjoyed a conference full of good science, excellent networking opportunities, and highly enjoyable social events. If you weren’t there, why not make a note for next year –
Tuesday 5 - Thursday 7 September 2017 at the University of
Hertfordshire .

See you there!"

Latest News
Applications invited for the 2017 Royal Pharmaceutical Society Science Award
MONDAY, 3 APRIL 2017
Applications are invited for the 2017 Royal Pharmaceutical Society Science Award. The winner will receive a Commemorative Award, £1,000 in prize money and an invitation to present the RPS Award Lecture on their work at the Academy of Pharmaceutical Sciences International PharmSci Conference meeting on Thursday 7th September 2017.. . Applications are welcome from scientists world-wide who are working in a pharmaceutical or allied discipline in industry or academia. With up to 10 years experience at post-doctoral level in September 2017, applicants must have a proven record of independent research and published work that shows outstanding promise. . . Applicants are invited to submit the following details by 31st May 2017:. . · Full CV detailing personal information, past and present appointments, research responsibilities and published work. . · List of research students who have worked for the applicant and their thesis titles and dates, plus any other instances of research collaborations . · Details of research grants awarded and the candidate’s role . · Invitations to speak at conferences in the UK and overseas, lecture or symposium titles and names of awards . · A brief resume of two pages should also be submitted with the CV, indicating discoveries made (please note copies of publications are not required). . . Applications should be made by 31th May preferably by email (colin.cable@rpharms.com) or by post to . Colin Cable, Assistant Chief Scientist. Royal Pharmaceutical Society. Holyrood Park House, 106 Holyrood Road, Edinburgh EH8 8AS.
APS 8th International PharmSci Conference 2017 Call for Abstracts
THURSDAY, 12 JANUARY 2017
. 'Pharmaceutical Sciences Without Borders’. Tuesday 5 – Thursday 7 September 2017 De Havilland Campus of the University of Hertfordshire in Hatfield. Call for Abstracts. Abstracts are invited for posters for APS International PharmSci 2017. This is one of the most exciting parts of the conference as it represents the presentation of the very latest pharmaceutical science research.. Abstracts on any aspect of the Pharmaceutical Sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, 'Pharmaceutical Sciences Without Borders’ are particularly appreciated. Details of the various subject categories, an abstract template and details of the entry process can be found here:. http://www.ukpharmsci.org/abstracts/default.asp. Please ensure abstracts are submitted online and comply with the Abstract Submission Template. Please note one or two page abstracts are welcomed providing they follow the template.. There will be prizes awarded for winning posters on each day of the Conference and authors of abstracts of particular interest will be invited to give podium presentations (15min). This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference. The closing date for abstract submission is Friday 17th March 2017.. Abstracts will be made available to Conference registrants when the abstract author has registered for the Conference. We also intend to publish the abstracts in a journal after the Conference and authors not wishing to take up this opportunity are requested to indicate this where indicated when they submit their abstract.. Entrants in the Analytical Chemistry category may be eligible for the Geoffrey Phillips Analytical Science Award, subject to meeting the criteria, awarded by the Joint Pharmaceutical Analysis Group (JPAG). The purpose of the Award is to encourage the advancement of pharmaceutical analysis and to recognise contributions of emerging scientists reporting wholly or mainly their own work. The winner receives a prestigious award with a bursary of up to £1000 to attend a conference relevant to their area of interest.. http://www.jpag.org/?&sid=20170112135948802597&p=awards#award. Exhibitor Opportunities. The conference includes a large pharmaceutical sciences exhibition, which is open to large pharma companies, small and medium size enterprises (SMEs), contract research organisations (CROs) and technology suppliers. With one of the largest gatherings of pharmaceutical scientists in the UK, the conference offers a great opportunity to showcase your company.. For more information please contact us: info@apsgb.org or 0116 274 7351. .
APS Fellowships Announcement 2017
WEDNESDAY, 2 NOVEMBER 2016
Do you know someone who has made a significant contribution to Pharmaceutical Science?. The APS is calling for nominations of candidates to become Fellow or Eminent Fellow of the Academy of Pharmaceutical Sciences.. Nominees for Fellowship must be a member of APS (for at least one year) and have a proven track record in pharmaceutical science, as demonstrated by at least 15 peer-reviewed publications, patents or equivalent. This would include significant contributions to the development of products or medical devises within the pharmaceutical industry. Nominees must also have demonstrated leadership and peer recognition through invited lectures, conference leadership, mentoring of young scientists etc. Candidates may self-nominate and nominations must consist of a one-page summary of achievements accompanies by a CV.. Nominations for Eminent Fellowship may be submitted by any member of APS but self-nominations are not accepted. Nominees for Eminent Fellowship must have international recognition for their advocacy of science and have demonstrated leadership at international level. Nominations should consist of a one-page summary of achievements and an explanation of why Eminent Fellowship is justified, and be accompanied by a CV.. Nominations should be sent to info@apsgb.org by 1 March 2017.
APS 8th International PharmSci Conference 2017
TUESDAY, 1 NOVEMBER 2016
. Tuesday 5 - Thursday 7 September 2017 De Havilland Campus, University of Hertfordshire, Hatfield. The theme of the conference in 2017 is. 'Pharmaceutical Science without Borders'. The APS is pleased to announce Professor Abdul Basit as the Conference Science Chair Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.. “I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is “Pharmaceutical Science without Borders”. Pharmaceutical science transcends a multitude of borders – it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event.”. . You can become part of this conference now,. Reserving the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.. . . . . . .
Follow us
 
Upcoming Events
APS Board and Advisory Board Meeting
12 July 2017
APS 8th International PharmSci Conference 2017
5 - 7 September 2017
APS Advances in Amorphous Design, Control and Delivery of Amorphous and Co-amorphous Pharmaceutical Materials
3 October 2017
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351
Fax: 0116 274 7365
Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.